BLCONYSEOphthalmic GoodsFiscal year ends December 31
Bausch & Lomb Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$16.61+0.12 (+0.73%)
Close on Oct 19, 2026
- Market cap
- $5.93B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
10.7%
38M of 357M shares
Institutional holders
98
19 new, 15 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
9 buys · 3 sales
Net bought $29.80K
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BLCO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Icahn Carl C | 3,500,000 | 0.98% | $57.96M | – | 0.70% |
| Oaktree Capital Management LP | 3,441,042 | 0.96% | $56.98M | +58,303 | 0.79% |
| Deutsche Bank AG\ | 3,423,046 | 0.96% | $56.69M | −105,395 | 0.02% |
| D. E. Shaw & Co., Inc. | 3,323,021 | 0.93% | $55.03M | +171,854 | 0.03% |
| Davidson Kempner Capital Management LP | 3,158,972 | 0.88% | $52.31M | +959,800 | 0.62% |
| Goldentree Asset Management LP | 2,660,508 | 0.74% | $43.96M | – | 2.56% |
| Price T Rowe Associates Inc /Md/ | 2,161,232 | 0.61% | $35.79K | +936,629 | 0.00% |
| Caspian Capital LP | 1,999,043 | 0.56% | $33.10M | – | 18.80% |
| Glenview Capital Management, LLC | 1,918,148 | 0.54% | $31.76M | +7,652 | 0.58% |
| Arrowstreet Capital, Limited Partnership | 1,364,980 | 0.38% | $22.60M | +382,918 | 0.01% |
| Citadel Advisors LLC | 987,730 | 0.28% | $16.36M | +282,509 | 0.00% |
| Clark Estates Inc/Ny | 881,000 | 0.25% | $14.59M | +56,000 | 3.36% |
| Morgan Stanley | 703,348 | 0.20% | $11.65M | −142,566 | 0.00% |
| Clearline Capital LP | 701,967 | 0.20% | $11.62M | – | 0.69% |
| Whitebox Advisors LLC | 686,976 | 0.19% | $11.38M | −414,878 | 0.15% |
| GordonMD Global Investments LP | 573,472 | 0.16% | $9.50M | – | 4.60% |
| Tudor Investment Corp Et Al | 532,030 | 0.15% | $8.81M | +155,584 | 0.01% |
| UBS Group AG | 465,197 | 0.13% | $7.70M | +12,018 | 0.00% |
| Goldman Sachs Group Inc | 420,194 | 0.12% | $6.96M | +127,308 | 0.00% |
| Sona Asset Management (US) LLC | 404,279 | 0.11% | $6.69M | New | 0.14% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 98 | 38M | 10.7% | 19 / 31 | 30 / 15 | 5M | 5M |
| Q1 2026 | 96 | 38M | 10.6% | 18 / 34 | 26 / 20 | 3M | 5M |
| Q4 2025 | 98 | 40M | 11.1% | 21 / 29 | 32 / 14 | 5M | 4M |
| Q3 2025 | 92 | 39M | 10.8% | 16 / 28 | 30 / 17 | 9M | 9M |
| Q2 2025 | 93 | 38M | 10.7% | 20 / 28 | 25 / 32 | 9M | 7M |
| Q1 2025 | 107 | 37M | 10.3% | 25 / 33 | 33 / 31 | 11M | 8M |
| Q4 2024 | 113 | 34M | 9.6% | 31 / 32 | 32 / 25 | 5M | 8M |
| Q3 2024 | 110 | 38M | 10.6% | 38 / 30 | 25 / 16 | 10M | 13M |
| Q2 2024 | 89 | 41M | 11.4% | 22 / 33 | 19 / 19 | 8M | 5M |
| Q1 2024 | 87 | 38M | 10.6% | 20 / 29 | 23 / 23 | 3M | 4M |
| Q4 2023 | 90 | 39M | 10.9% | 21 / 36 | 16 / 17 | 5M | 9M |
| Q3 2023 | 87 | 43M | 12.1% | 17 / 23 | 24 / 7 | 7M | 8M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of BLCO | Value | % of fund | As of |
|---|---|---|---|---|---|
| T. Rowe Price High Yield Fund, Inc. | 791,542 | 0.22% | $12.39M | 0.20% | May 31, 2026 |
| T. Rowe Price Institutional High Yield Fund | 210,028 | 0.06% | $3.29M | 0.20% | May 31, 2026 |
| T. Rowe Price Dynamic Credit Fund | 204,491 | 0.06% | $3.39M | 0.23% | Jun 30, 2026 |
| Ballast Small/Mid Cap ETF | 147,837 | 0.04% | $2.45M | 1.37% | Jun 30, 2026 |
| T. Rowe Price Global High Income Bond Fund | 61,989 | 0.02% | $1.03M | 0.17% | Jun 30, 2026 |
| T. Rowe Price Credit Opportunities Fund, Inc. | 50,600 | 0.01% | $791.89K | 0.20% | May 31, 2026 |
| The Gabelli Asset Fund | 45,000 | 0.01% | $745.20K | 0.04% | Jun 30, 2026 |
| Strategic Advisers Income Opportunities Fund | 43,655 | 0.01% | $683.20K | 0.04% | May 31, 2026 |
| International Core Equity 2 Portfolio | 15,594 | 0.00% | $263.69K | 0.00% | Jul 31, 2026 |
| 1290 GAMCO Small/Mid Cap Value Fund | 15,000 | 0.00% | $253.65K | 0.11% | Jul 31, 2026 |
| Dimensional World ex. U.S. Core Equity 2 ETF | 13,782 | 0.00% | $233.05K | 0.00% | Jul 31, 2026 |
| World ex U.S. Core Equity Portfolio | 11,157 | 0.00% | $188.66K | 0.00% | Jul 31, 2026 |
| Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF | 9,389 | 0.00% | $112.88K | 0.04% | Jul 31, 2026 |
| International Sustainability Core 1 Portfolio | 7,203 | 0.00% | $121.80K | 0.00% | Jul 31, 2026 |
| Dimensional International Core Equity 2 ETF | 2,558 | 0.00% | $43.26K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Brent L. Saunders | Chairman of the Board and CEO, Director | 974,158 | 0.27% | Aug 7, 2026 |
| Frederick Munsch | SVP, Controller and CAO | 45,831 | 0.01% | Aug 12, 2026 |
| Sam Eldessouky | EVP and CFO | 393,527 | 0.11% | Aug 7, 2026 |
| Luc Bonnefoy | President, Surgical | 103,801 | 0.03% | Aug 7, 2026 |
| Yehia Hashad | EVP of R&D and CMO | 187,350 | 0.05% | Aug 7, 2026 |
| Andrew J. Stewart | President, GPIC | 103,211 | 0.03% | Aug 7, 2026 |
| A. Robert D. Bailey | EVP & Chief Legal Officer | 264,241 | 0.07% | Aug 7, 2026 |
| Robert J. Chersi | Director | 11,776 | 0.00% | Aug 14, 2026 |
| Laurence E. Paul | Director | 11,776 | 0.00% | Aug 14, 2026 |
| Barbara Trebbi | Director | 11,776 | 0.00% | Aug 14, 2026 |
| Thomas Appio | Director | 27,583 | 0.01% | Aug 14, 2026 |
| Eschenbach Andrew C. Von | Director | 63,733 | 0.02% | Aug 10, 2026 |
| John Paulson | Director | 89,823 | 0.03% | May 28, 2026 |
| Steven H. Collis | Director | 42,003 | 0.01% | May 28, 2026 |
| Thomas W. Ross Sr. | Director | 85,233 | 0.02% | May 28, 2026 |
| Russel C. Robertson | Director | 94,260 | 0.03% | May 28, 2026 |
| Sarah B. Kavanagh | Director | 69,541 | 0.02% | May 28, 2026 |
| Karen Ling | Director | 61,518 | 0.02% | May 28, 2026 |
| Eduardo Alfonso | Director | 31,072 | 0.01% | May 28, 2026 |
| Nathalie D. Bernier | Director | 85,505 | 0.02% | May 28, 2026 |
| Brett Icahn | Director | 61,147 | 0.02% | May 28, 2025 |
| Gaoxiang Hu | Director | 61,147 | 0.02% | May 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Robert J. Chersi Director | Aug 12, 2026 | Award | +11,776 | – | – | 11,776 |
| Barbara Trebbi Director | Aug 12, 2026 | Award | +11,776 | – | – | 11,776 |
| Laurence E. Paul Director | Aug 12, 2026 | Award | +11,776 | – | – | 11,776 |
| Frederick Munsch SVP, Controller and CAO | Aug 10, 2026 | Sale | −52,900 | $16.78 | $887.66K | 45,831 |
| Eschenbach Andrew C. Von Director | Aug 7, 2026 | Sale | −6,059 | $16.58 | $100.46K | 63,733 |
| Eschenbach Andrew C. Von Director | Aug 6, 2026 | Sale | −12,500 | $16.50 | $206.25K | 69,792 |
| Yehia Hashad EVP of R&D and CMO | Aug 5, 2026 | Award | +20,973 | – | – | 187,350 |
| Andrew J. Stewart President, GPIC | Aug 5, 2026 | Award | +16,778 | – | – | 103,211 |
| Sam Eldessouky EVP and CFO | Aug 5, 2026 | Award | +50,335 | – | – | 393,527 |
| A. Robert D. Bailey EVP & Chief Legal Officer | Aug 5, 2026 | Award | +33,557 | – | – | 264,241 |
| Luc Bonnefoy President, Surgical | Aug 5, 2026 | Award | +16,778 | – | – | 103,801 |
| Frederick Munsch SVP, Controller and CAO | Aug 5, 2026 | Award | +9,091 | – | – | 98,731 |
| Brent L. Saunders Chairman of the Board and CEO, Director | Aug 5, 2026 | Tax withholding | −4,231 | $16.76 | $70.91K | 974,158 |
| Brent L. Saunders Chairman of the Board and CEO, Director | Aug 5, 2026 | Award | +281,879 | – | – | 1,256,037 |
| Luc Bonnefoy President, Surgical | Jun 12, 2026 | Tax withholding | −1,008 | $15.08 | $15.20K | 87,023 |
| Steven H. Collis Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 42,003 |
| John Paulson Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 89,823 |
| Thomas W. Ross Sr. Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 85,233 |
| Nathalie D. Bernier Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 85,505 |
| Karen Ling Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 61,518 |
| Eschenbach Andrew C. Von Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 86,656 |
| Russel C. Robertson Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 94,260 |
| Eduardo Alfonso Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 31,072 |
| Sarah B. Kavanagh Director | May 26, 2026 | Award | +15,842 | $15.78 | $249.99K | 69,541 |
| Brent L. Saunders Chairman of the Board and CEO, Director | May 22, 2026 | Tax withholding | −2,886 | $15.92 | $45.95K | 978,389 |
| Yehia Hashad EVP of R&D and CMO | May 5, 2026 | Tax withholding | −13,664 | $16.00 | $218.62K | 166,377 |
| Frederick Munsch SVP, Controller and CAO | May 5, 2026 | Tax withholding | −8,673 | $16.00 | $138.77K | 89,640 |
| Luc Bonnefoy President, Surgical | May 5, 2026 | Tax withholding | −11,970 | $16.00 | $191.52K | 88,031 |
| Sam Eldessouky EVP and CFO | May 5, 2026 | Tax withholding | −63,938 | $16.00 | $1.02M | 343,192 |
| Eduardo Alfonso Director | Apr 30, 2026 | Award | +1,375 | $15.90 | $21.86K | 15,230 |
| John Paulson Director | Apr 30, 2026 | Award | +1,375 | $15.90 | $21.86K | 73,981 |
| Russel C. Robertson Director | Apr 30, 2026 | Award | +1,611 | $15.90 | $25.61K | 78,418 |
| Steven H. Collis Director | Apr 30, 2026 | Award | +1,415 | $15.90 | $22.50K | 26,161 |
| A. Robert D. Bailey EVP & Chief Legal Officer | Apr 24, 2026 | Tax withholding | −15,806 | $15.82 | $250.05K | 230,684 |
| Andrew J. Stewart President, GPIC | Apr 24, 2026 | Tax withholding | −4,216 | $15.82 | $66.70K | 86,433 |
| Sam Eldessouky EVP and CFO | Mar 6, 2026 | Award | +4,000 | – | – | 407,130 |
| Sam Eldessouky EVP and CFO | Mar 6, 2026 | Buy | +4,000 | $17.13 | $68.52K | 403,130 |
| Brent L. Saunders CEO and Chairman of the Board, Director | Mar 6, 2026 | Buy | +14,700 | $17.14 | $251.96K | 966,575 |
| Brent L. Saunders CEO and Chairman of the Board, Director | Mar 6, 2026 | Award | +14,700 | – | – | 981,275 |
| A. Robert D. Bailey EVP & Chief Legal Officer | Mar 6, 2026 | Buy | +14,600 | $17.15 | $250.39K | 231,890 |
| A. Robert D. Bailey EVP & Chief Legal Officer | Mar 6, 2026 | Award | +14,600 | – | – | 246,490 |
| Thomas W. Ross Sr. Director | Mar 3, 2026 | Award | +4,500 | – | – | 69,391 |
| Thomas W. Ross Sr. Director | Mar 3, 2026 | Buy | +4,500 | $17.68 | $79.56K | 64,891 |
| Eduardo Alfonso Director | Mar 2, 2026 | Award | +4,300 | – | – | 13,855 |
| Eduardo Alfonso Director | Mar 2, 2026 | Buy | +4,300 | $17.90 | $76.97K | 9,555 |
| Eschenbach Andrew C. Von Director | Feb 27, 2026 | Buy | +4,364 | $18.31 | $79.90K | 66,450 |
| Eschenbach Andrew C. Von Director | Feb 27, 2026 | Award | +4,364 | – | – | 70,814 |
| Andrew J. Stewart President, GPIC | Feb 27, 2026 | Tax withholding | −2,007 | $18.30 | $36.73K | 90,649 |
| A. Robert D. Bailey EVP & Chief Legal Officer | Feb 27, 2026 | Tax withholding | −2,461 | $18.30 | $45.04K | 217,290 |
| Yehia Hashad EVP of R&D and CMO | Feb 27, 2026 | Tax withholding | −11,621 | $18.30 | $212.66K | 180,041 |
| Yehia Hashad EVP of R&D and CMO | Feb 27, 2026 | Tax withholding | −5,075 | $18.30 | $92.87K | 191,662 |
| Sam Eldessouky EVP and CFO | Feb 27, 2026 | Tax withholding | −15,507 | $18.30 | $283.78K | 450,600 |
| Sam Eldessouky EVP and CFO | Feb 27, 2026 | Tax withholding | −51,470 | $18.30 | $941.90K | 399,130 |
| Luc Bonnefoy President, Surgical | Feb 27, 2026 | Tax withholding | −4,311 | $18.30 | $78.89K | 109,222 |
| Luc Bonnefoy President, Surgical | Feb 27, 2026 | Tax withholding | −9,221 | $18.30 | $168.74K | 100,001 |
| Brent L. Saunders CEO and Chairman of the Board, Director | Feb 27, 2026 | Tax withholding | −24,649 | $18.30 | $451.08K | 951,875 |
| Frederick Munsch SVP, Controller and CAO | Feb 27, 2026 | Tax withholding | −2,437 | $18.30 | $44.60K | 104,005 |
| Frederick Munsch SVP, Controller and CAO | Feb 27, 2026 | Tax withholding | −5,692 | $18.30 | $104.16K | 98,313 |
| Andrew J. Stewart President, GPIC | Feb 26, 2026 | Tax withholding | −2,984 | $18.49 | $55.17K | 92,656 |
| A. Robert D. Bailey EVP & Chief Legal Officer | Feb 26, 2026 | Tax withholding | −3,395 | $18.49 | $62.77K | 219,751 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Karen Ling Former Director | Sep 28, 2026 | 4,500 | $75.74K | Sep 28, 2026 | Restricted Stock Vesting |
| Frederick Munsch Officer | Aug 11, 2026 | 52,900 | $887.89K | Aug 10, 2026 | Restricted Stock Vesting |
| Frederick Munsch Former Officer | Aug 10, 2026 | 52,900 | $887.89K | Aug 10, 2026 | Restricted Stock Vesting |
| Eschenbach Andrew C. Von Former Director | Aug 7, 2026 | 6,059 | $100.43K | Aug 7, 2026 | Open market purchase |
| Eschenbach Andrew C. Von Former Director | Aug 6, 2026 | 12,500 | $206.19K | Aug 6, 2026 | Restricted Stock Vesting |